0001819934-20-000001.txt : 20200803 0001819934-20-000001.hdr.sgml : 20200803 20200803124124 ACCESSION NUMBER: 0001819934-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200803 DATE AS OF CHANGE: 20200803 EFFECTIVENESS DATE: 20200803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmbAgon Therapeutics Inc. CENTRAL INDEX KEY: 0001819934 IRS NUMBER: 850560627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372342 FILM NUMBER: 201068525 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 235-6373 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0708 D LIVE 0001819934 AmbAgon Therapeutics Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 (415) 235-6373 DELAWARE None None Corporation true 2020 Christian Ottmann c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Michelle Arkin c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Lucas Brunsveld c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Janwillem Naesens c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Margarita Chavez c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Peter Dudek c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Roel Bulthuis c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Adam Rosenberg c/o AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2020-07-17 true true false 0 7199998 7199998 0 Series Seed Preferred Stock and the Common Stock issuable upon the conversion thereof. false 8 0 0 0 false AmbAgon Therapeutics Inc. /s/Christian Ottmann Christian Ottmann Chief Executive Officer 2020-07-29